Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

449 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
The receptor that tames the innate immune response.
Brines M, Cerami A. Brines M, et al. Among authors: cerami a. Mol Med. 2012 May 9;18(1):486-96. doi: 10.2119/molmed.2011.00414. Mol Med. 2012. PMID: 22183892 Free PMC article. Review.
ARA290, a Specific Agonist of Erythropoietin/CD131 Heteroreceptor, Improves Circulating Endothelial Progenitors' Angiogenic Potential and Homing Ability.
Hache G, Garrigue P, Bennis Y, Stalin J, Moyon A, Cerami A, Brines M, Blot-Chabaud M, Sabatier F, Dignat-George F, Guillet B. Hache G, et al. Among authors: cerami a. Shock. 2016 Oct;46(4):390-7. doi: 10.1097/SHK.0000000000000606. Shock. 2016. PMID: 27172159
ARA290 Improves Insulin Release and Glucose Tolerance in Type 2 Diabetic Goto-Kakizaki Rats.
Muller C, Yassin K, Li LS, Palmblad M, Efendic S, Berggren PO, Cerami A, Brines M, Ă–stenson CG. Muller C, et al. Among authors: cerami a. Mol Med. 2016 May;21(1):969-978. doi: 10.2119/molmed.2015.00267. Epub 2015 Dec 29. Mol Med. 2016. PMID: 26736179 Free PMC article.
ARA 290 improves symptoms in patients with sarcoidosis-associated small nerve fiber loss and increases corneal nerve fiber density.
Dahan A, Dunne A, Swartjes M, Proto PL, Heij L, Vogels O, van Velzen M, Sarton E, Niesters M, Tannemaat MR, Cerami A, Brines M. Dahan A, et al. Among authors: cerami a. Mol Med. 2013 Nov 8;19(1):334-45. doi: 10.2119/molmed.2013.00122. Mol Med. 2013. PMID: 24136731 Free PMC article. Clinical Trial.
Delayed administration of pyroglutamate helix B surface peptide (pHBSP), a novel nonerythropoietic analog of erythropoietin, attenuates acute kidney injury.
Patel NS, Kerr-Peterson HL, Brines M, Collino M, Rogazzo M, Fantozzi R, Wood EG, Johnson FL, Yaqoob MM, Cerami A, Thiemermann C. Patel NS, et al. Among authors: cerami a. Mol Med. 2012 May 9;18(1):719-27. doi: 10.2119/molmed.2012.00093. Mol Med. 2012. PMID: 22415011 Free PMC article.
A nonerythropoietic peptide that mimics the 3D structure of erythropoietin reduces organ injury/dysfunction and inflammation in experimental hemorrhagic shock.
Patel NS, Nandra KK, Brines M, Collino M, Wong WF, Kapoor A, Benetti E, Goh FY, Fantozzi R, Cerami A, Thiemermann C. Patel NS, et al. Among authors: cerami a. Mol Med. 2011 Sep-Oct;17(9-10):883-92. doi: 10.2119/molmed.2011.00053. Epub 2011 May 13. Mol Med. 2011. PMID: 21607291 Free PMC article.
Nonerythropoietic tissue protective compounds are highly effective facilitators of wound healing.
Erbayraktar Z, Erbayraktar S, Yilmaz O, Cerami A, Coleman T, Brines M. Erbayraktar Z, et al. Among authors: cerami a. Mol Med. 2009 Jul-Aug;15(7-8):235-41. doi: 10.2119/molmed.2009.00051. Epub 2009 Apr 16. Mol Med. 2009. PMID: 19593407 Free PMC article.
A small nonerythropoietic helix B surface peptide based upon erythropoietin structure is cardioprotective against ischemic myocardial damage.
Ahmet I, Tae HJ, Juhaszova M, Riordon DR, Boheler KR, Sollott SJ, Brines M, Cerami A, Lakatta EG, Talan MI. Ahmet I, et al. Among authors: cerami a. Mol Med. 2011 Mar-Apr;17(3-4):194-200. doi: 10.2119/molmed.2010.00235. Epub 2010 Dec 16. Mol Med. 2011. PMID: 21170473 Free PMC article.
A surprising journey in translational medicine.
Cerami A. Cerami A. Mol Med. 2014 Dec 16;20 Suppl 1(Suppl 1):S2-6. doi: 10.2119/molmed.2014.00209. Mol Med. 2014. PMID: 25549228 Free PMC article. No abstract available.
Farewell statement from Dr. Cerami and Dr. Tracey as outgoing co-Editors in Chief of Molecular Medicine.
Cerami A, Tracey KJ. Cerami A, et al. Mol Med. 2014 Aug 8;20(1):329-30. doi: 10.2119/molmed.2014.00151. Mol Med. 2014. PMID: 25356559 Free PMC article. No abstract available.
449 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page